Randomized controlled trial of videoconference based cognitive behavial therapy for stressor-related disorders and stressor-related depression

Shimizu Eiji0 sites30 target enrollmentFebruary 8, 2023

Overview

No summary available.

Registry

who.int

Start Date

February 8, 2023

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Shimizu Eiji

•Patients who meet all of the following criteria set to target
•1\) Have a diagnosis of stressor related disorders group(adjustment disorders, adjustment\-like disorders, unspecified stressor\-related disorder) or stressor related depressive disorders( major depressive disorder, persistent depressive disorder) with a current episode of distress or disability with emotional or behavioral symptoms within 3 months in response to a clearly identified stressor
•3\) Between 16 and 65 years old
•4\) Given written consent of their own free will (16 and 17 years old who have been fully informed of the study and who have given written consent of their own free will by themselves and their guardians)
•5\) Have a mental and physical condition that allows them to understand and sustainably practice cognitive behavioal therapy for at least 2 months
•6\) Have the ability and environment to use the Internet and computers to receive cognitive behavioal therapy using a videoconferencing system
•7\) To attend their physician, with or without medication, but no new medications or changes in medication are planned in the future

•Those who meet any of the following conditions are not eligible.
•1\) Organic mental disorder, psychosis including schizophrenia, bipolar disorder, mental retardation, autism spectrum disorder, substance abuse/substance dependence disorder, and those at imminent risk of suicide
•2\) Post Traumatic Stress Disorder(PTSD), Acute Stress Disorder
•3\) Persons on trail (including those in mediation)
•4\) Have difficulty in contacting the researchers
•5\) Judged to be inappropriate for conducting this study safely by the researchers